We also compared GSCs derived from IDH-mutant, ATRX-mutant (08-0537) and IDH-mutant, ATRX wild-type (TS 603) gliomas, finding increased nuclear G4s in the former by BG4 immunofluorescence (Fig. 1d). The gene discussed is IDH1; the disease is central nervous system cancer.